Table 3.

Potential clinical outcomes of documentation errors and medication classes involved

Category	Errors N (%)	Identified medication groups
Potentially fatal	0	Nil identified
Potentially serious	14 (2.4%)	Anti-infective for systemic use (quinolones, beta-lactams, aminoglycosides); nervous system (antiepileptic drugs); blood and blood-forming organs (antiplatelet and anticoagulants)
Potentially significant	61 (10.3%)	Cardiovascular system (antihypertensive drugs, lipid modifying agents); alimentary tract and metabolism (drugs for peptic ulcers, antinauseants and antiemetics, drugs for constipation); nervous system (opioid analgesics, drugs indicated for analgesics and antipyretics)
Potentially non-significant	518 (87.4%)	Vitamin and mineral supplements

Notes: Potentially serious outcomes were calculated from all anti-infective systemic use, 1 anti-epileptic drug, 1 antiplatelet, and 1 anticoagulant. Meanwhile, potentially non significant outcomes were calculated based on medication administered but not documented (N=513), plus 1 general nutrient, 2 various (multivitamins), and 2 immunomodulating agents.